Healthcare provider profile · identity verified

Alberto Lira, M.D.

Family Practice · HUTCHINSON, MN · NPI 1730265232

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	313	73
Rosuvastatin Calcium	Rosuvastatin Calcium	283	84
Metformin Hcl Er	Metformin Hcl	263	67
Metoprolol Succinate	Metoprolol Succinate	257	66
Lisinopril	Lisinopril	246	65
Omeprazole	Omeprazole	239	61
Tamsulosin Hcl	Tamsulosin Hcl	232	52
Levothyroxine Sodium	Levothyroxine Sodium	221	56
Simvastatin	Simvastatin	199	56
Irbesartan	Irbesartan	196	53
Amlodipine Besylate	Amlodipine Besylate	163	47
Losartan Potassium	Losartan Potassium	138	34
Pantoprazole Sodium	Pantoprazole Sodium	132	33
Montelukast Sodium	Montelukast Sodium	123	33
Gabapentin	Gabapentin	121	31
Sertraline Hcl	Sertraline Hcl	121	21
Allopurinol	Allopurinol	117	30
Eliquis	Apixaban	112	22
Furosemide	Furosemide	106	29
Pioglitazone Hcl	Pioglitazone Hcl	106	29
Atenolol	Atenolol	82	22
Ozempic	Semaglutide	81	12
Duloxetine Hcl	Duloxetine Hcl	77	18
Potassium Chloride	Potassium Chloride	76	21
Metoprolol Tartrate	Metoprolol Tartrate	73	20
Quetiapine Fumarate	Quetiapine Fumarate	70	14
Fluoxetine Hcl	Fluoxetine Hcl	69	18
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	69	12
Warfarin Sodium	Warfarin Sodium	61	17
Pravastatin Sodium	Pravastatin Sodium	60	22
Finasteride	Finasteride	57	suppressed
Jantoven	Warfarin Sodium	56	suppressed
Indapamide	Indapamide	55	14
Donepezil Hcl	Donepezil Hcl	54	14
Xarelto	Rivaroxaban	53	suppressed
Glipizide Er	Glipizide	51	17
Clopidogrel	Clopidogrel Bisulfate	50	15
Trazodone Hcl	Trazodone Hcl	50	14
Famotidine	Famotidine	49	13
Carvedilol	Carvedilol	48	12
Albuterol Sulfate Hfa	Albuterol Sulfate	45	18
Torsemide	Torsemide	44	suppressed
Nifedipine Er	Nifedipine	43	14
Citalopram Hbr	Citalopram Hydrobromide	42	11
Ipratropium Bromide	Ipratropium Bromide	39	suppressed
Prednisone	Prednisone	39	25
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	38	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	38	11
Klor-Con M20	Potassium Chloride	38	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	37	19
Alendronate Sodium	Alendronate Sodium	36	12
Escitalopram Oxalate	Escitalopram Oxalate	36	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	35	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	35	11
Venlafaxine Hcl Er	Venlafaxine Hcl	33	suppressed
Memantine Hcl	Memantine Hcl	32	suppressed
Jardiance	Empagliflozin	27	suppressed
Olanzapine	Olanzapine	26	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	26	suppressed
Metformin Hcl	Metformin Hcl	25	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	25	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	23	suppressed
Spironolactone	Spironolactone	23	suppressed
Tramadol Hcl	Tramadol Hcl	23	suppressed
Ventolin Hfa	Albuterol Sulfate	23	suppressed
Ketoconazole	Ketoconazole	22	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	22	suppressed
Lorazepam	Lorazepam	22	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	21	suppressed
Semglee (Yfgn) Pen	Insulin Glargine-Yfgn	21	suppressed
Ezetimibe	Ezetimibe	20	suppressed
Synthroid	Levothyroxine Sodium	20	suppressed
Amoxicillin	Amoxicillin	19	suppressed
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	19	11
Imiquimod	Imiquimod	19	13
Klor-Con M10	Potassium Chloride	19	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Cefadroxil	Cefadroxil	17	13
Meclizine Hcl	Meclizine Hcl	17	suppressed
Raloxifene Hcl	Raloxifene Hcl	17	suppressed
Ropinirole Hcl	Ropinirole Hcl	17	suppressed
Metronidazole	Metronidazole	16	11
Trulicity	Dulaglutide	16	suppressed
Digoxin	Digoxin	15	suppressed
Januvia	Sitagliptin Phosphate	15	suppressed
Otezla	Apremilast	15	suppressed
Propranolol Hcl Er	Propranolol Hcl	15	suppressed
Tizanidine Hcl	Tizanidine Hcl	15	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	15	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	14	suppressed
Diclofenac Sodium	Diclofenac Sodium	14	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	14	suppressed
Methotrexate	Methotrexate Sodium	14	suppressed
Mirtazapine	Mirtazapine	14	suppressed
Oxycodone Hcl	Oxycodone Hcl	14	suppressed
Acyclovir	Acyclovir	13	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	13	suppressed
Valsartan	Valsartan	13	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Baclofen	Baclofen	12	suppressed
Cephalexin	Cephalexin	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	11	suppressed
Calcipotriene	Calcipotriene	11	suppressed
Cholestyramine Light	Cholestyramine	11	suppressed
Cyclosporine Modified	Cyclosporine, Modified	11	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	11	suppressed
Dutasteride	Dutasteride	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Methimazole	Methimazole	11	suppressed
Mupirocin	Mupirocin	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error